Sangeetha Reddy

Breast cancer medical oncologist, translational researcher and clinical trialist with focus on immunotherapy and the tumor microenvironment

[Sangeetha Reddy @smreddymd]

Grateful to have been part of this important work on dual immune checkpoint blockade in metastatic breast cancers! Congrats to all the authors!

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

The #NIMBUS trial results are now published in @NatureComms 👉Nivolumab plus low-dose #ipilimumab in hypermutated HER2-negative #MetastaticBreastCancer.
🔓https://t.co/uYjsMiSqlY
✍️@jgtzanudo @smreddymd @EmensLeisha @CarolinaAlvesC5 @s_aldubayan @hoyin_chu @nlinmd
@NabihahTayob @RMJesel @EMittendorfMD
@stolaney1

[Qing Zhang @QingZhangLab]

#AACR25, capturing the last night at AACR grantee award reception along with ⁦@utswcancer⁩ colleague ⁦@smreddymd⁩ ! Managed to take a photo with the one and only ⁦@AACR_CEO⁩ !Thanks the grant support from ⁦@AACR⁩ ⁦@kidneycan⁩

[Qing Zhang @QingZhangLab]

Big congratulations @smreddymd @utswcancer !!

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

@UTSWInternalMed #GrandRounds with @smreddymd highlighting immunotherapy for breast cancer and her translational efforts. Our breast cancer team is strong @utswcancer @UTSWHemeOnc! @CarlosArteagaMD @suzanneconzenmd @hmcarthur

[Sangeetha Reddy @smreddymd]

@hmcarthur @BCRFcure Congratulations!!

[Sangeetha Reddy @smreddymd]

Big congrats!!!

[Isaac Chan, MD, PhD @ithinkichan]

Read it here: https://t.co/OGzDdFGzaj Happy to talk more- How can we use our lab's tools & data to help you?

Led by Lily Xu @UTSWMedCenter Med student, Katilyn Saunders, and Shawn Huang @UTSWmstp. 🙏 to funders @SusanGKomen @metavivor @theNCI. Collab w/ @GRASPtweets who gave *great* patient insight & Lin Xu, @smreddymd @hmcarthur @utswcancer, & my dear friend who knows @tomhanks @RoussosTorres. @UTSWHemeOnc @BiotechClubUTSW @UTSWInternalMed @UTSWCancerBio @CellRepMed

[Sangeetha Reddy @smreddymd]

Excited to share our updated pre-clinical data on combination CD40 agonist + Flt3L + Doxil in breast cancer with @PreteeshLeo. @utswcancer #aacr24

[Sangeetha Reddy @smreddymd]

@andyzwang @TiansterZhang @utswcancer Completely agree! Congrats @TiansterZhang!

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer @DrRBarroso @stolaney1 @nlinmd @nabihahtayob @emittendorfmd @RMJesel @smreddymd

[Naoto T Ueno, MD, PhD @teamoncology]

After my wonderful experience at @MDAndersonNews, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research. #SABCS23

[SABCS @SABCSSanAntonio]

Tumor Agnostic Approaches to Care: @VivekSubbiah, Joshua Z. Drago, @DrMiaLevy, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23.
@lab_kok @smreddymd @AACR @UTHealthSAMDA @OncoAlert

[Sangeetha Reddy @smreddymd]

Looking forward to moderating this session and hearing some stellar talks in Stars at Night Ballroom in just a few minutes! @SABCSSanAntonio @utswcancer #sabcs23

[MarleenKokLab @lab_kok]

Join us for tumor-agnostic session @SABCSSanAntonio #SABCS23. What can we as BC physicians and investigators learn from other tumor types and how best to collaborate! With stellar speakers @VivekSubbiah

[Sangeetha Reddy @smreddymd]

@brekkenlab @utswcancer You did great! And clearly lot of interest in the subject.

[Sangeetha Reddy @smreddymd]

Fantastic talk at #SITC2023 by @brekkenlab @utswcancer on Immune Regulation by Stromal Cells!

[soria @jsoriamd]

The cancer #immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. Check out this revised review that helps better understand the successes & failures of cancer #immunotherapy https://t.co/6SOsXMKRwM

[Jarushka Naidoo @DrJNaidoo]

It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’

Both

The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness

Great paper @ESMO_Open @DrJonLim
https://t.co/dlzC3z0S77

[Kathryn Gallaway, MD @KE_Gallaway]

Highlighting the important role the innate immune system plays in immunotherapy, @smreddymd delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast https://t.co/NoyipOB2mR

[Sangeetha Reddy @smreddymd]

@RoussosTorres @AACR @bcrf @uscnorris @KeckMedUSC Congratulations!! Well deserved :)

[Sangeetha Reddy @smreddymd]

Excited to share our work with @avilgelm showing dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade!

https://t.co/HIcEKa1Biq

[Sangeetha Reddy @smreddymd]

@immunegirl Congratulations! So happy for you!